Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Short-term Investments: 2018-2025

Historic Short-term Investments for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Sep 2025 value amounting to $31,001.

  • China SXT Pharmaceuticals' Short-term Investments was N/A to $31,001 in Q3 2025 from the same period last year, while for Sep 2025 it was $31,001, marking a year-over-year change of. This contributed to the annual value of $30,413 for FY2025, which is 344.50% up from last year.
  • China SXT Pharmaceuticals' Short-term Investments amounted to $31,001 in Q3 2025, which was up 1.93% from $30,413 recorded in Q1 2025.
  • Over the past 5 years, China SXT Pharmaceuticals' Short-term Investments peaked at $45,297 during Q1 2022, and registered a low of $6,842 during Q1 2024.
  • Over the past 2 years, China SXT Pharmaceuticals' median Short-term Investments value was $30,413 (recorded in 2025), while the average stood at $22,752.
  • In the last 5 years, China SXT Pharmaceuticals' Short-term Investments tumbled by 74.58% in 2022 and then skyrocketed by 344.50% in 2025.
  • Over the past 4 years, China SXT Pharmaceuticals' Short-term Investments (MRQ) stood at $25,947 in 2021, then skyrocketed by 74.58% to $45,297 in 2022, then crashed by 84.90% to $6,842 in 2024, then surged by 353.10% to $31,001 in 2025.
  • Its last three reported values are $31,001 in Q3 2025, $30,413 for Q1 2025, and $6,842 during Q1 2024.